Private label continues to grow across key product categories in Europe, especially where consumers value affordability, quality, and ethical production. Leading segments include: ...

BOSTON-- (BUSINESS WIRE)-- Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced ...

ALPHA-SOLAR is a long-term open-label trial in adults with HAE Type 1 or 2 designed to assess long-term safety and efficacy of navenibart. All 16 target enrollment participants from the Phase 1b/2 ...

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive initial results ...

European label trends FINAT managing director Jules Lejeune looked at the European label business landscape in 2024 and 2025. Following the supply chain disruption in 2022 and destocking of materials ...

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive initial results from ...

To qualify for the “Finance Europe” label, investment products must have at least 70% of assets in the European Economic Area, primarily in equities. They must also include an incentive for ...

Seven EU countries, including Luxembourg, have launched the “Finance Europe” savings label, an initiative aimed at encouraging more retail investors to put their savings into longer-term investment ...